February 2017 Newsletter

February 16, 2017:

Glaucoma 360 Presenters Say Future Treatments May Combine Technologies

Speakers envision custom therapies that merge MIGS devices with extended-release drugs.

February 16, 2017:

India Eyes Broad Medical Device Regulation

The government plans to scrutinize devices based on the risk they pose.

February 16, 2017:

Jonathan Talamo, MD, Discusses Pipeline at Ocular Therapeutix

The surgeon also talked about his transition to chief medical officer.

February 16, 2017:

Novartis CEO Jimenez Says He May Spin Off Alcon after Disappointing 2016

A major restructuring of Alcon remains a work in progress, while competitive pressures weigh on the division's cataract and refractive segments.

February 16, 2017:

Alcon Launches PanOptix Trifocal Toric IOL

The lens gained CE marking in November 2016.

February 16, 2017:

Novartis Discusses Ophthalmic Pipeline, $465M Acquisition of Encore Vision

Novartis paid $375 million up front, plus $90 million in early milestone payments, for presbyopia technology.

February 16, 2017:

Regeneron’s Eylea Sales in US Increase 15 Percent in Q4-2016

Company told analysts it is no longer pursuing its PDGF program after clinical trial failure in 2016.

February 16, 2017:

Allergan’s Restasis Revenues Up 13 Percent in Q4-2016

Dry eye market has expanded 30 percent since mid-2016, CCO says.

February 16, 2017:

Ophthotech Names New President, Retools Following Fovista Failure

Glenn Sblendorio has moved into the role following the departure of company co-founder Samir Patel, MD.

February 16, 2017:

Q4-2017 Earnings Roundup

Abbott Medical Optics reported a 7.7 percent increase in revenues for Q4-2017, while Carl Zeiss Meditec saw quarterly revenues grow 6.6 percent.

February 16, 2017:

Dry Eye Procedures Find Footing, as Market Expands Rapidly

TearScience’s LipiFlow procedure has seen marked growth in the last year.

February 16, 2017:

Novaliq Announces Positive Phase II Results for CyclASol, a Dry Eye Treatment Candidate

The technology is designed to enhance the topical bioavailability, stability, and safety of traditionally insoluble or unstable drugs.

February 16, 2017:

Hydrophobic IOLs Expected to Increase Market Dominance with Improvements

Leading manufacturers have been addressing disadvantages and improving other characteristics of the material.

February 16, 2017:

February 2017 Retina News Briefs

AGTC and Bionic Sight will collaborate on an optogenetic treatment to restore retinal function; and Pixium Vision announces that 10 patients have been implanted with the Iris II retinal prosthesis.

February 16, 2017:

Market Report: China’s Ophthalmic Market to Grow to $4 Billion by 2022

Retinal disease is the largest ophthalmic segment in the country due to the role of anti-VEGFs in treatment.

February 16, 2017:

Market Report: Ophthalmic OR Microscope Market to See Nearly 7 Percent Growth over Next Five Years

The US market will represent nearly a third of global revenues, as older units are replaced and prices rise.

February 16, 2017:

Nicox Plans Phase II Study of NCX 470 in Glaucoma; Also Awaits Launch of Vyzulta

France-based firm plans to file an IND application for its nitric oxide-donating bimatoprost analog in Q4-2017.

February 16, 2017:

Phoenix Equity Partners Acquires Stake in Rayner

Financial details of the deal were not disclosed.

February 16, 2017:

ASCRS to Induct Gullapalli N. Rao, Karl Koller into Ophthalmology Hall of Fame

Honorees are chosen by more than 30 thousand ophthalmologists around the world.

February 16, 2017:

February 2017 News Briefs

Social media